Lu Q L, Hanby A M, Nasser Hajibagheri M A, Gschmeissner S E, Lu P J, Taylor-Papadimitriou J, Krajewski S, Reed J C, Wright N A
Histopathology Unit, Imperial Cancer Research Fund, London, UK.
J Cell Sci. 1994 Feb;107 ( Pt 2):363-71. doi: 10.1242/jcs.107.2.363.
bcl-2 gene expression confers a survival advantage by preventing cells from entering apoptosis. In contrast to the previously described cytoplasmic localization of Bcl-2 in epithelial cells in vivo, in this study we have demonstrated, in a series of human epithelial cell lines, that Bcl-2 also localizes to mitotic nuclei. Both immunocytochemical and immunoelectron microscopical examinations localize this protein to nuclei and in particular to chromosomes. Nuclear Bcl-2 expression in these cell lines is correlated with the cell cycle. There is relatively strong expression during mitosis, most intense during prophase and metaphase, declining in telophase and then the protein becomes undetectable soon after separation of the two daughter cells. The expression and distribution of Bcl-2 is influenced by treatment with excessive thymidine. These results indicate that Bcl-2 may protect the cells from apoptosis occurring during mitosis and suggest a possible role for the protein in cell immortalization.
bcl-2基因表达通过阻止细胞进入凋亡而赋予生存优势。与先前描述的体内上皮细胞中Bcl-2的细胞质定位相反,在本研究中,我们在一系列人类上皮细胞系中证明,Bcl-2也定位于有丝分裂细胞核。免疫细胞化学和免疫电子显微镜检查均将该蛋白定位于细胞核,特别是染色体。这些细胞系中核Bcl-2的表达与细胞周期相关。在有丝分裂期间表达相对较强,在前期和中期最强,在末期下降,然后在两个子细胞分离后不久该蛋白就无法检测到。Bcl-2的表达和分布受过量胸苷处理的影响。这些结果表明,Bcl-2可能保护细胞免受有丝分裂期间发生的凋亡,并提示该蛋白在细胞永生化中可能发挥的作用。